RxDoctor Payments Data

Alan Voegele, PA

Surgical · Sartell, MNNPI 1831580356

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 64.2% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $266, 4.3 times the $61 reported in 2021.

$800in general payments, 2019–2025

Across 40 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$513
  • Relievant Medsystems, Inc.$113
  • Si-bone, Inc.$37
  • Vertos Medical, Inc.$37
  • SPR Therapeutics, Inc$32
  • Saluda Medical Americas, Inc.$31
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$800100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$800 in reported general payments places this provider in the 80th percentile of 121 surgical providers in Minnesota.

See all surgical providers in Minnesota

Medicare billing

Part B allowed, 2024
$100,792
Medicare patients
233
Services billed
5,817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl49$17,939
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen264$8,397
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen205$4,566
Oxycodone Hcl190$4,112
Gabapentin161$3,743
Morphine Sulfate ErMorphine Sulfate137$3,632
Fentanyl23$2,617
Tramadol Hcl112$1,196
Pregabalin49$1,078
Duloxetine Hcl54$1,069
Baclofen42$681
Tizanidine Hcl34$630
Cyclobenzaprine Hcl43$528
Morphine Sulfate17$448
Celecoxib20$321

Paid to pharmacies, not to this prescriber.

Other surgical in Sartell

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →